Bonapam 60mg Injection
By Bonapam
Rx
1 Injection in a Vial

Composition
Pamidronate(60mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
July, 2026

liver
When using Bonapam 60mg Injection, it is important to be cautious in patients with severe liver disease. It may be necessary to adjust the dose of the injection. Please make sure to consult your doctor before starting treatment with Bonapam 60mg Injection if you have severe liver disease. Limited information is currently available regarding the use of Bonapam 60mg Injection in patients with severe liver disease. However, in patients with mild to moderate liver disease, no dose adjustment is required. It is always best to seek advice from your healthcare provider to ensure the safe and appropriate use of the injection in the context of liver issues.

kidney
Bonapam 60mg Injection requires caution in severe kidney disease. Dosage adjustment may be necessary. Consult your doctor for guidance.

alcohol
When taking Bonapam 60mg Injection, it is safe to consume alcohol as it does not result in any negative effects.

driving
When taking Bonapam 60mg Injection, be cautious as it may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Bonapam 60mg Injection is not recommended during pregnancy due to the potential risk to the developing baby. It may only be used in critical situations where benefits outweigh risks, under the doctor's guidance. Consulting your doctor is advised.

breastfeeding
Bonapam 60mg Injection requires caution during breastfeeding. It is recommended to suspend breastfeeding until the mother's treatment is finished and the drug is no longer present in her system. If used during breastfeeding, monitor the baby's blood calcium levels for the first two months.
| Habit Forming | No |
| Chemical Class | Bisphosphonate Derivative |
| Therapeutic Class | PAIN ANALGESICS |
| Action Class | Bone resorption inhibitor -Bisphosphonates |
₹4200
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024
